Antibiotic use as a marker of acute infection and risk of first and recurrent venous thrombosis

Br J Haematol. 2017 Mar;176(6):961-970. doi: 10.1111/bjh.14551. Epub 2017 Feb 17.

Abstract

A role for transient infections in the aetiology of venous thrombosis (VT) has been suggested. This study aimed to determine whether individuals who receive antibiotic treatment (as a proxy for infections) have an increased risk of first and recurrent VT and whether infections should be seen as a provoking risk factor for VT. We used the self-controlled case series method to study the risk of first VT during antibiotic prescriptions. The risk of recurrent VT during antibiotic use was estimated by of time-dependent Cox-regression. A total of 2547 patients with a first VT were included and followed for a median of 5·9 years for recurrence (1999-2010), in whom 114 first events occurred during antibiotic use. We found a five-fold increased risk of first VT during antibiotic treatment: [incidence-rate-ratio 5·0; 95% confidence interval (CI), 4·0-6·1]. Antibiotic use was associated with a 2·0-fold (95% CI, 1·1-4·0) increased risk of recurrent VT. Patients with an unprovoked first VT who used antibiotics shortly before this event, had a similar risk of recurrence as patients with a provoked first VT (adjusted hazard ratio 1·1; 95% CI, 0·7-1·7). Individuals who receive antibiotics have an increased risk of first and recurrent VT and infections should be considered a provoking risk factor for VT.

Keywords: antibiotics; epidemiology; infection; recurrence; venous thrombosis.

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Biomarkers
  • Female
  • Humans
  • Infections / complications*
  • Infections / drug therapy*
  • Infections / etiology
  • Male
  • Middle Aged
  • Prognosis
  • Recurrence
  • Risk
  • Treatment Outcome
  • Venous Thrombosis / diagnosis*
  • Venous Thrombosis / etiology*
  • Venous Thrombosis / therapy
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Biomarkers